PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer
Clinical trial NCT05967884 · UNKNOWN
Trial details
- NCT number
- NCT05967884
- Sponsor
- Ottawa Hospital Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2024-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.